2022 ACC/AHA guideline for the diagnosis and management of aortic disease: a report of the American Heart Association/American College of Cardiology Joint …

Writing Committee Members, EM Isselbacher… - Journal of the American …, 2022 - jacc.org
Abstract Aim The “2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic
Disease” provides recommendations to guide clinicians in the diagnosis, genetic evaluation …

Non-coding RNAs as blood-based biomarkers in cardiovascular disease

RF Videira, PA da Costa Martins… - International journal of …, 2020 - mdpi.com
In 2020, cardiovascular diseases (CVDs) remain a leading cause of mortality and morbidity,
contributing to the burden of the already overloaded health system. Late or incorrect …

Epigenetic influences on genetically triggered thoracic aortic aneurysm

SS Portelli, EN Robertson, C Malecki, KA Liddy… - Biophysical …, 2018 - Springer
Genetically triggered thoracic aortic aneurysms (TAAs) account for 30% of all TAAs and can
result in early morbidity and mortality in affected individuals. Epigenetic factors are now …

Identification of hemodynamic biomarkers for bicuspid aortic valve induced aortic dilation using machine learning

P Franco, J Sotelo, A Guala, L Dux-Santoy… - Computers in biology …, 2022 - Elsevier
Recent advances in medical imaging have confirmed the presence of altered
hemodynamics in bicuspid aortic valve (BAV) patients. Therefore, there is a need for new …

[HTML][HTML] 2022 ACC/AHA Guideline for the diagnosis and management of aortic disease

JA Beckman, WC Members - Journal of the American College of …, 2022 - ncbi.nlm.nih.gov
AIM The “2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease”
provides recommendations to guide clinicians in the diagnosis, genetic evaluation and …

[HTML][HTML] 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology …

JA Beckman, WC Members - Circulation, 2022 - ncbi.nlm.nih.gov
AIM: The “2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease”
provides recommendations to guide clinicians in the diagnosis, genetic evaluation and …

An exploratory look at bicuspid aortic valve (Bav) aortopathy: focus on molecular and cellular mechanisms

C Mozzini, D Girelli, L Cominacini, M Soresi - Current problems in …, 2021 - Elsevier
Bicuspid aortic valve (BAV) is the most common congenital heart malformation. BAV patients
are at increased risk for aortic valve disease (stenosis/regurgitation), infective endocarditis …

Circulating soluble receptor of advanced glycation end product is associated with bicuspid aortic aneurysm progression via NF-κB pathway

H Jia, L Kang, S Lu, Z Chen, J Shen… - Interactive …, 2022 - academic.oup.com
OBJECTIVES Patients with bicuspid aortic valve (BAV) have a high risk of aortic dilation and
adverse vascular events. Previous studies had reported soluble receptor for advanced …

Light on the molecular and cellular mechanisms of bicuspid aortic valve to unveil phenotypic heterogeneity

CR Balistreri, E Cavarretta, S Sciarretta… - Journal of molecular and …, 2019 - iris.unipa.it
Research on bicuspid aortic valve disease (BAV) and related complications has grown in an
exponential manner in the last decades. However, the current knowledge of the …

[PDF][PDF] 二叶式主动脉瓣主动脉扩张机制的研究进展

白莹, 靳巧锋, 何书坤, 刘天舒, 邓文惠… - 临床心血管病 …, 2023 - lcxxgen.whuhzzs.com
二叶式主动脉瓣主动脉扩张机制的研究进展∗ Page 1 2023,39 临床心血管病杂志 (2):93-98
JournalofClinicalCardiology(China) 引用本文:白莹,靳巧锋,何书坤,等.二叶式主动脉瓣主动脉 …